Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains
Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains
The binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) was studied in rat and human brain synaptic membranes. Specific binding was saturable, reversible and inhibited by a range of compounds active at N-methyl-D-aspartate (NMDA) receptors such as 2-amino-5-phosphonopentanoate (AP5), 2-amino-7-phosphonoheptanoate (AP7), NMDA and cis-2,4-methanoglutamate. Binding was heterogeneous as evidenced by non-linear Scatchard plots and Hill coefficients for binding inhibitors significantly different from unity. LIGAND analysis of the binding data indicated the likely presence of two distinct binding components for CPP, one of high (Kd values approx. = 70 nM) and the other of low (Kd values approx. 5 μM) affinity. Possible alterations in the binding of [3H]CPP to either site were investigated in medial frontal and medial temporal cortex from Alzheimer's disease brains and compared with control tissues, carefully matched for age and postmortem delay. While there were considerable inter-individual variations in binding, no significant differences were detected either between brain regions in either Alzheimer or control subjects, or between Alzheimer's disease and control brains. These data suggest the presence of at least two components of [3H]CPP binding in both rat and human brain tissue. The integrity of neither of these components is altered in Alzheimer's disease, consistent with a lack of gross alterations of NMDA receptors in this disorder.
Alzheimer's disease, Brain (rat), Cortex (human), NMDA receptors, [H]CPP([H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)
195-197
Porter, Richard H.P.
d977ae5c-0112-4ea7-8a8e-951b03a94649
Cowburn, Richard F.
a5d9f8e5-7785-4726-9b11-9143c2c3f593
Alasuzoff, Irina
63b7136f-d926-4c9b-a299-d49c291a3306
Briggs, Roger S.J.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Roberts, Peter J.
ab0ce3bd-e5a0-42a9-818c-ad502d7789f3
12 March 1992
Porter, Richard H.P.
d977ae5c-0112-4ea7-8a8e-951b03a94649
Cowburn, Richard F.
a5d9f8e5-7785-4726-9b11-9143c2c3f593
Alasuzoff, Irina
63b7136f-d926-4c9b-a299-d49c291a3306
Briggs, Roger S.J.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Roberts, Peter J.
ab0ce3bd-e5a0-42a9-818c-ad502d7789f3
Porter, Richard H.P., Cowburn, Richard F., Alasuzoff, Irina, Briggs, Roger S.J. and Roberts, Peter J.
(1992)
Heterogeneity of NMDA receptors labelled with [3H]3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
European Journal of Pharmacology: Molecular Pharmacology, 225 (3), .
(doi:10.1016/0922-4106(92)90020-V).
Abstract
The binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) was studied in rat and human brain synaptic membranes. Specific binding was saturable, reversible and inhibited by a range of compounds active at N-methyl-D-aspartate (NMDA) receptors such as 2-amino-5-phosphonopentanoate (AP5), 2-amino-7-phosphonoheptanoate (AP7), NMDA and cis-2,4-methanoglutamate. Binding was heterogeneous as evidenced by non-linear Scatchard plots and Hill coefficients for binding inhibitors significantly different from unity. LIGAND analysis of the binding data indicated the likely presence of two distinct binding components for CPP, one of high (Kd values approx. = 70 nM) and the other of low (Kd values approx. 5 μM) affinity. Possible alterations in the binding of [3H]CPP to either site were investigated in medial frontal and medial temporal cortex from Alzheimer's disease brains and compared with control tissues, carefully matched for age and postmortem delay. While there were considerable inter-individual variations in binding, no significant differences were detected either between brain regions in either Alzheimer or control subjects, or between Alzheimer's disease and control brains. These data suggest the presence of at least two components of [3H]CPP binding in both rat and human brain tissue. The integrity of neither of these components is altered in Alzheimer's disease, consistent with a lack of gross alterations of NMDA receptors in this disorder.
This record has no associated files available for download.
More information
Published date: 12 March 1992
Keywords:
Alzheimer's disease, Brain (rat), Cortex (human), NMDA receptors, [H]CPP([H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid)
Identifiers
Local EPrints ID: 479049
URI: http://eprints.soton.ac.uk/id/eprint/479049
ISSN: 0922-4106
PURE UUID: a6380e0e-b3a0-46bb-ac14-90aa69102152
Catalogue record
Date deposited: 19 Jul 2023 16:37
Last modified: 17 Mar 2024 03:36
Export record
Altmetrics
Contributors
Author:
Richard H.P. Porter
Author:
Richard F. Cowburn
Author:
Irina Alasuzoff
Author:
Roger S.J. Briggs
Author:
Peter J. Roberts
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics